Evidence map›Paper›PMID 28925029›Full record

ArticleGlia2017

Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.

Alex K Ray, Juwen C DuBois, Ross C Gruber, Hillary M Guzik, Maria E Gulinello, Geoffrey Perumal, Cedric Raine, Lauren Kozakiewicz, Julie Williamson, Bridget Shafit-Zagardo

Open access · greenAbstract read
In one paragraph

Article in Glia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Growth arrest specific protein 6 alleviated white matter injury after experimental ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  11. Article
  12. Article
  13. Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. AXL, an Important Host Factor for DENV and ZIKV Replication.Frontiers in cellular and infection microbiology · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Alex K RayDepartment of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, 10461.ORCID 0000-0001-5760-7821
Juwen C DuBoisDepartment of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, 10461.
Ross C GruberNeuroimmunology and MS Research, Sanofi, Framingham, Massachusetts, 01701.
Hillary M GuzikDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York, 10461.
Maria E GulinelloRodent Behavioral Core, Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York, 10461.
Geoffrey PerumalDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York, 10461.
Cedric RaineDepartment of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, 10461.
Lauren KozakiewiczDepartment of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, 10461.
Julie WilliamsonDepartment of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, 10461.
Bridget Shafit-ZagardoDepartment of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, 10461.
Albert Einstein College of Medicine · USInstitute of Neuroimmunology of the Slovak Academy of Sciences · SK

Funding

Support for the Rose F. Kennedy IDDRCU54HD090260 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GREALLY, JOHN · 2016 to 2020
$6.0M
Translational Neuroimaging CoreP30HD071593 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI WALKLEY, STEVEN UPSHAW · 2011 to 2015
$5.6M
Molecular NeuropathologyT32NS007098 · NINDS · YESHIVA UNIVERSITY · PI SANTAMBROGIO, LAURA · 1985 to 2015
$5.0M
Anti-Axl and anti-Mer antibody treatment to reduce the clinical course of EAER21NS093134 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHAFIT-ZAGARDO, BRIDGET · 2016 to 2017
$459k
High-speed/resolution whole slide scanner supported by two core facilitiesS10OD019961 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CONDEELIS, JOHN S · 2015 to 2015
$326k
NICHD NIH HHS P30 HD071593NICHD NIH HHS U54 HD090260NIH HHS S10 OD019961NINDS NIH HHS R21 NS093134NINDS NIH HHS T32 NS007098
6 · The paper itself

Abstract

The TAM (Tyro3, Axl, and MerTK) family of receptor tyrosine kinases (RTKs) and their ligands, Gas6 and ProS1, are important for innate immune responses and central nervous system (CNS) homeostasis. While only Gas6 directly activates Axl, ProS1 activation of Tyro3/MerTK can indirectly activate Axl through receptor heterodimerization. Therefore, we generated Gas6

Indexed as

Movement DisordersAnimalsAxl Receptor Tyrosine KinaseAxonsCuprizoneDemyelinating DiseasesDisease Models, AnimalEncephalitisGene Expression RegulationGrowth Arrest-Specific Protein 6Intercellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMice, TransgenicMonoamine Oxidase InhibitorsMyelin SheathAxl Receptor Tyrosine KinaseAXL receptor tyrosine kinase, mouseCuprizoneGrowth Arrest-Specific Protein 6Intercellular Signaling Peptides and ProteinsMonoamine Oxidase InhibitorsNerve Tissue ProteinsProto-Oncogene ProteinsReceptor Protein-Tyrosine Kinasesaxonal damagedemyelinationmotor deficitsneuroinflammationTAM signaling

Identifiers

PMID28925029
PMCPMC5643251
OpenAlexW2754685627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.